Mobia Medical, Inc. is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The Company’s Vivistim Paired Vagus Nerve Stimulation (Paired VNS) System is the clinically validated, FDA-approved solution for chronic ischemic stroke survivors with moderate to severe upper extremity impairments. The Vivistim System includes an implantable device that stimulates the vagus nerve only when intentionally activated, triggering the release of neuromodulators, including acetylcholine, norepinephrine, and serotonin. Its neuromodulators create a heightened state of plasticity in the brain, such that neural networks can more readily adapt and reform in response to stimuli. The implantable components of the Vivistim System-namely, the implantable pulse generator (IPG) and lead-are implanted through a minimally invasive outpatient procedure that takes approximately 60 minutes.
Símbolo de cotizaciónMOBI
Nombre de la empresaMobia Medical Inc
Fecha de salida a bolsaMay 08, 2026
Director ejecutivoFoust (Richard John)
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscal- -
Dirección2802 Flintrock Trace, Suite 226
Ciudad
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal78738
Teléfono
Sitio Web
Símbolo de cotizaciónMOBI
Fecha de salida a bolsaMay 08, 2026
Director ejecutivoFoust (Richard John)
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos